Home HD with NxStage Boosts Transplant Chances

More than 5,000 people have received a kidney transplant after doing more frequent home HD with a NxStageⓇ System One—a rate 14% higher than among those who do standard in-center HD.

Read the full article » | Posted 01-11-2018

Related Articles

• Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features Posted 07-13-2022
• Baxter Showcases Kidney Care Products Posted 06-10-2022
• DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022
• Outset Tablo Could Boost Use of Home Hemodialysis Posted 05-12-2022